Related Experiment Video
Updated: Sep 13, 2025

Sensitive Measurement of Mitophagy by Flow Cytometry Using the pH-dependent Fluorescent Reporter mt-Keima
Published on: August 12, 2018
Nanotechnology-targeted modulation of mitophagy in cancer therapy: Progress and challenges
Hongyu Yang1, Chang Peng1, Hanjie Sun1
1Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, No. 103, Wenhua Road, Shenyang, 110016, PR China.
Abstract:
The clinical efficacy of current cancer treatments remains insufficient, creating an urgent need to identify new therapeutic targets and combine them with traditional treatment methods. Mitophagy, a crucial mechanism for the intracellular clearance of damaged mitochondria, has shown tremendous potential in cancer therapy. However, accurately and effectively regulating mitophagy remains a significant challenge. In some years, nanoparticle-based drug delivery systems have attracted considerable attention due to their high targeting ability and deep tissue penetration. Therefore, applying nanotechnology to regulate mitophagy may offer new therapeutic strategies for cancer treatment. This review provides a comprehensive overview of the recent advances in the targeted regulation of mitophagy using nanotechnology, including the use of nanoparticle carriers alone or in combination with other cancer therapies. Additionally, we discuss the development of mitophagy, the relevant signaling pathways, the relationship between mitophagy and cancer, drugs that modulate mitophagy, and methods for detecting mitophagy. Finally, we explore the prospects and challenges of using nanotechnology to target and regulate mitophagy in cancer therapy. STATEMENT OF SIGNIFICANCE: This review underscores the therapeutic relevance of mitophagy in cancer, focusing on its selective role in mitochondrial quality control and tumor regulation. Given the challenges in precise mitophagy modulation, we highlight the emergence of nanotechnology based delivery systems as a promising solution. The review covers mitophagy mechanisms, associated pathways, detection techniques, mitophagy modu lating agents, and nanoparticle strategies- both standalone and combinatorial. It further discusses translational opportunities and technical barriers, offering a concise, integrative perspective on how nanomedicine can enable targeted mitophagy interventio n for improved cancer therapy.
Insights
Nanotechnology offers novel strategies to precisely regulate mitophagy, a cellular process vital for cancer therapy. This approach enhances mitochondrial quality control and tumor regulation, paving the way for improved cancer treatments.
Area of Science:
- Biomedical Engineering
- Oncology
- Cellular Biology
Background:
- Current cancer treatments have limited clinical efficacy, necessitating novel therapeutic targets.
- Mitophagy, the clearance of damaged mitochondria, presents significant therapeutic potential in cancer.
- Precise regulation of mitophagy remains a challenge in cancer therapy.
Purpose of the Study:
- To provide a comprehensive overview of nanotechnology-based strategies for targeted mitophagy regulation in cancer therapy.
- To discuss the mechanisms, pathways, and detection methods related to mitophagy in cancer.
- To explore the prospects and challenges of using nanomedicine for mitophagy modulation in cancer treatment.
Main Methods:
- Review of recent advances in nanotechnology for mitophagy regulation.
- Analysis of nanoparticle-based drug delivery systems for targeted cancer therapy.
- Discussion of standalone and combinatorial nanoparticle strategies.
Main Results:
- Nanotechnology enables targeted delivery and regulation of mitophagy.
- Nanoparticle systems offer high targeting ability and deep tissue penetration.
- Combinatorial approaches with existing therapies show promise.
Conclusions:
- Nanotechnology provides a promising avenue for precise mitophagy modulation in cancer.
- Targeted mitophagy regulation via nanomedicine can improve cancer treatment efficacy.
- Further research is needed to overcome translational and technical barriers.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Drugs that Stabilize Microtubules
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Drugs that Destabilize Microtubules
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...

